Evidence map›Paper›PMID 35614212›Full record

ArticleNature2022

Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes.

Sophia Maschalidi, Parul Mehrotra, Burcu N Keçeli, Hannah K L De Cleene, Kim Lecomte, Renée Van der Cruyssen, Pauline Janssen, Jonathan Pinney, Geert van Loo, Dirk Elewaut and 3 more

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 155 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 2 pooled it
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 2 syntheses or guidelines pooled it, 284 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Sophia MaschalidiUnit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium. sophia.maschalidi@irc.vib-ugent.be.ORCID http://orcid.org/0000-0002-8245-8925
Parul Mehrotra *Unit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium.
Burcu N Keçeli *Unit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium.
Hannah K L De CleeneUnit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium.ORCID http://orcid.org/0000-0002-3466-0643
Kim LecomteDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0001-8402-9799
Renée Van der CruyssenDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Pauline JanssenLaboratory of Neuro-Aging and Viro-Immunotherapy, Center for Neurosciences (C4N), Vrije Universiteit Brussel, Brussels, Belgium.
Jonathan PinneyThe Center for Cell Clearance, University of Virginia, Charlottesville, VA, USA.
Geert van LooDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-8427-4775
Dirk ElewautDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-7468-974X
Ann MassieLaboratory of Neuro-Aging and Viro-Immunotherapy, Center for Neurosciences (C4N), Vrije Universiteit Brussel, Brussels, Belgium.ORCID http://orcid.org/0000-0002-8418-5879
Esther HosteDepartment of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-3181-431X
Kodi S RavichandranUnit for Cell Clearance in Health and Disease, VIB Center for Inflammation Research, Ghent, Belgium. kodi@wustl.edu.ORCID http://orcid.org/0000-0001-9049-1410
Ghent University · BEGhent University Hospital · BEVrije Universiteit Brussel · BEUniversity College Ghent · BEUniversity of Virginia · US

Funding

Role of Pannexins in Vascular Smooth Muscle CellsP01HL120840 · NHLBI · UNIVERSITY OF VIRGINIA · PI BAYLISS, DOUGLAS A., RAVICHANDRAN, KODI S · 2014 to 2023
$24.0M
Solute carrier proteins in efferocytosis and inflammationR01AI159551 · NIAID · WASHINGTON UNIVERSITY · PI RAVICHANDRAN, KODI S · 2021 to 2025
$2.9M
Mechanisms regulating apoptotic cell clearance in health and diseaseR35GM122542 · NIGMS · WASHINGTON UNIVERSITY · PI RAVICHANDRAN, KODI S · 2017 to 2021
$2.3M
European Research CouncilNHLBI NIH HHS P01 HL120840NIAID NIH HHS R01 AI159551NIGMS NIH HHS R35 GM122542
6 · The paper itself

Abstract

Chronic non-healing wounds are a major complication of diabetes, which affects 1 in 10 people worldwide. Dying cells in the wound perpetuate the inflammation and contribute to dysregulated tissue repair

Indexed as

Amino Acid Transport System y+Dendritic CellsDiabetes MellitusPhagocytosisWound HealingAnimalsGluconeogenesisGlucoseGlycolysisGrowth Differentiation Factor 15MiceAmino Acid Transport System y+Gdf15 protein, mouseGlucoseGrowth Differentiation Factor 15Slc7a11 protein, mouse

Identifiers

PMID35614212
OpenAlexW4281483912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.